Commercial Impact

Discovery Science,Brought to Market.

From HairGenesis® — the first scientifically-proven, naturally-based hair loss treatment, generating $100M+ in revenue across 25 countries with up to three decades of customer loyalty — to government-sanctioned nutraceutical concessions in the GCC and Europe's best-selling wellness range, Continuum Innovative carries a multi-decade, multi-territory track record of translating mechanism-led science into commercial reality.

$100M+

Total HairGenesis® revenue generated

Countries distributed worldwide

30 yrs

Of demonstrated customer loyalty

1994

First to market — naturally-based hair loss

Past · The Foundational Record

Three decades of mechanism-led commercialization.

The science platform proved itself in market — across hair biology, systemic nutraceuticals, and licensed brand expansion — over multiple territories and multiple generations of formulation.

HairGenesis® product family — HairGenesis®
7 generations · 25 countries

D²Maxx™ Vitamin D₂ — D²Maxx™
Qatar national health concession

maxmedix™ Hair-Plus
Licensed IP · EU launch

maxmedix™ Candida Support
EU wellness range

Hair Biology · Consumer Health · 1994 – Present

HairGenesis®

Before HairGenesis®, no scientifically validated, demonstrably proven, naturally-based hair loss treatment existed. The proprietary botanically-derived formula combines targeted DHT blockade with anti-inflammatory compounds — a multi-faceted approach grounded in a University at Albany collaboration and published in a peer-reviewed medical journal in 2011. Now in its seventh generation, HairGenesis® has been distributed in 25 countries, generated over $100M in total retail and wholesale revenue at $20M+ annually, and retained customers for as long as three decades.

First to market (1994) · naturally-based hair loss
25 countries · $100M+ total revenue · $20M+/yr
Peer-reviewed validation (Univ. at Albany, 2011)
Up to 30 years of demonstrated customer loyalty

Nutraceutical · GCC · Government Concession

D²Maxx™

Originated through a strategic partnership with GCC-based clinician and scientist entrepreneurs, D²Maxx™ is a proprietary vitamin D₂ formulation that was awarded the sole, government-sanctioned concession for distribution throughout the entire national health infrastructure of Qatar — encompassing hospitals, health clinics, and the private sector — with planned expansion across the UAE and broader GCC region.

Exclusive Qatar national health concession
Distribution: hospitals, clinics & private sector
GCC clinician-scientist co-development
UAE & GCC regional expansion roadmap

Hair & Wellness · European Union · Licensed IP

maxmedix™

A new-business-venture licensing model: Continuum's proprietary technology, IP, and expertise were licensed to launch a hair loss treatment line under the maxmedix™ brand. Backed by broad distribution and strong capitalization, maxmedix™ has grown to constitute the best-selling range of wellness products in the European Union — a textbook demonstration of how Continuum's science platform scales through the right partner.

Licensed IP & formulation expertise
Best-selling wellness range in the EU
Partner-led capitalization & distribution
Repeatable license-and-launch model

Next-Gen Delivery Platform · IP Validated

TrichoCyte™

Enhanced drug-delivery of naturally-derived hair-stimulating compounds — a botanically-derived formula invaginated within β-cyclodextrin, with longitudinal clinical photography (Day 0 → Day 270) substantiating regrowth. The IP and delivery platform underpinning today's clinically-deployed formulations.

Explore TrichoCyte™

◆

GCC Retail Footprint · UAE & KSA

Proof of shelf. Across the Gulf.

A decade-plus of formal GCC market presence — from 2014 registration through multi-country pharmacy, hospital, and hypermarket distribution — placing HairGenesis® on the mainline shelves of the region's leading retail health channels alongside category-defining brands.

HairGenesis® Oral Tablets on the mainline hair-loss shelf at Boots UAE, alongside Vitabiotics, Vichy, and Nourkrin. — Boots UAE · HairGenesis® Oral Tablets, mainline hair-loss shelf

United Arab Emirates

Multi-channel retail penetration

In-market execution across the UAE's leading pharmacy banners, hospital pharmacies, and hypermarket health aisles — supported by branded gondola end-caps, group displays, and promotional pack programs.

HairGenesis® branded gondola end-cap at Boots UAE

HairGenesis® group display at Al Ain Pharmacy, UAE

HairGenesis® display at Life Pharmacy, UAE

HairGenesis® promotional offer pack, UAE pharmacy channel, 2019

Kingdom of Saudi Arabia

Bilingual, in-store campaign execution

Full storefront take-overs at partner pharmacies in KSA — window vinyls, door clings, and shelf-talkers — all bilingual (Arabic / English) and fully HairGenesis®-branded for the Saudi consumer.

HairGenesis® bilingual campaign creative — women's line, Saudi Arabia

HairGenesis® bilingual campaign creative — men's line, Saudi Arabia

Bilingual creative · Arabic + English

Channel Reach · Retail Banners Carrying HairGenesis®

From Boots to Bloomingdale's.

Plus hospital pharmacies, hypermarkets & department-store beauty halls

Al Manara PharmacyAmerican Hospital DubaiMediclinicMedcareNMC HospitalsDebenhamsBloomingdale'sUnion CoopAbu Dhabi CoopShefa Pharmacy (KSA)Maithar Pharmacy (KSA)

2014

Formal GCC market entry

2017

Regional distribution infrastructure in place

2019

Multi-country retail execution & promo programs

2026

Re-engagement — seeking best-in-class GCC partner

Formal GCC market entry corroborated by 2014 Arizona Secretary of State apostille documentation on file — establishing a decade-plus continuous regional presence.

Present · Active Commercialization

The platform, deployed in clinical and consumer channels today.

Continuum's proprietary formulations are presently in market through a network of device, clinical, and consumer partners — each delivering our science under their own brand and channel.

Device & Distribution Partner

CryoConcepts

Hub of our present-day clinical deployment. CryoConcepts manufactures and distributes the CryoTouch MD Topical Carboxy Delivery (TCD) device — the in-clinic delivery platform that carries our proprietary formulations into dermatologic and aesthetic practice. The CryoTouch MD Hair Restoration Protocol is the flagship application.

See CryoTouch MD

Clinical Practice · TrichoBoost™

GetHairMD

Clinical practice deploying our proprietary TrichoBoost™ formulation — wholesaled to them through CryoConcepts — via the CryoWave CX protocol. A textbook example of platform formulation reaching clients through a partnered clinical channel.

View CryoWave CX

Direct-to-Consumer · Wholesaled via CryoConcepts

Skin Clinic 4 Hair

A second set of proprietary Continuum formulations — this one direct-to-consumer — produced by us and wholesaled to CryoConcepts for distribution under the Skin Clinic 4 Hair brand. Same science platform, consumer channel.

Direct-to-Consumer Line

Consumer-Facing Title · Amazon

Healthy Hair Made Simple

Clinically-proven, plain-language guidance for clients and clinicians navigating common pattern hair loss — distributed via Skin Clinic on Amazon. The accessible front door to decades of mechanism-led research.

View on Amazon

III · Future

The Next Idea.

Every formulation on this page began as a single line of thought.

The next one hasn't been written yet. It is waiting for the right partner, the right question, the right moment — and a science platform ready to translate it into clinical and commercial reality.

We bring great ideas to life.
Bring us yours.

Start a Conversation Collaboration Models

Real-World Outcomes

My wife says I look years younger!

Jackson B., Jr.· Reno, NV

Who We Partner With

Built for partners who move science into markets.

We are actively engaging with international commercialization partners, brand operators, co-development partners, and strategic investors — particularly those positioned to build markets and category strategy around botanically-derived science in new territories.

Start a Partner Conversation Collaboration Models

International Commercialization Partners

Established consumer-health, pharmacy, and dermatology channels positioned to build markets, shape category strategy, and create long-term value for differentiated, science-backed botanical formulations in their region.

Explore a Commercialization Partnership

Brand & Licensee Partners

Brand operators seeking to license proven formulation IP under their own label or co-branded structures.

Discuss a Licensing Structure

Co-Development Partners

Formulators, contract manufacturers, and clinical groups interested in joint development of next-generation programs.

Propose a Co-Development Program

Strategic & Investment Partners

Corporate development and investment groups seeking platform-stage opportunities at the intersection of botanical science and translational medicine.

Open a Strategic Conversation

Clinical Partners

Retail reach meets clinical credibility.

Beyond 25+ years of GCC pharmacy distribution, Continuum Innovative programs are actively deployed inside US medical practice. Prestige Medical Group (Tustin & Santa Ana, California) runs CryoTouch™ MD with TrichoCyte® SML — combining TrichoCyte®'s nano-encapsulated botanical actives with topical carboxy delivery — as their non-surgical hair restoration protocol.

The combination — regional retail scale plus live clinical use in an American medical group — gives licensing partners a platform validated on both sides of the commercialization pathway.

See the clinical protocol